The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
Open accessAbstract
The role of low density lipoprotein (LDL) receptors in the pathogenesis of hereditary and acquired forms of hypercholesterolemia has been investigated in vivo by simultaneously determining total and receptor-independent LDL catabolism with 125I-labeled LDL and 131I-labeled LDL coupled with cyclohexanedione. Receptor-mediated catabolism of LDL, determined as the difference between the turnover of 125I and 131I, was found to be virtually absent in two homozygotes with familial hypercholesterolemia and markedly reduced in a hypothyroid patient. Treatment of the latter with L-thyroxine markedly stimulated receptor-mediated catabolism and reduced LDL levels as did cholestyramine administration in a control subject. Reduction of LDL levels by plasma exchange in a control subject and homozygote had no such effect. These results demonstrate the existence of an intrinsic and almost total defect of receptor-mediated LDL catabolism in homozygous familial hypercholesterolemia and demontrate an analogous but reversible abnormality in hypothyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
Goldstein, J. L., & Brown, M. S. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42341-7 · Cited by 1,123
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
Langer, T., Strober, W., & Levy, R. I. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106949 · Cited by 629
Brown, M. S., & Goldstein, J. L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.788 · Cited by 596
Patthy, L., & Smith, E. L. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41933-9 · Cited by 385
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
Shepherd, J., Packard, C. J., Bicker, S., Lawrie, T. D. V., & Morgan, H. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022202 · Cited by 357
WALTON, K. W., Scott, P., Dykes, P. W., & Davies, J. W. L. (1965) · PubMed · Cited by 241
Receptor-mediated low density lipoprotein catabolism in man.
Shepherd, J., Bicker, S., Lorimer, A. R., & Packard, C. J. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40002-1 · Cited by 182
Goldstein, J. L., Dana, S. E., Brunschede, G. Y., & Brown, M. S. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1092 · Cited by 178
Cited by
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 755
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Hypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
Brown, M. S., & Goldstein, J. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111044 · Cited by 545
Effects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M. S., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 392
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Ladenson, P. W., Kristensen, J. D., Ridgway, E. C., Olsson, A. G., Carlsson, B., Klein, I., Baxter, J. D., & Angelin, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905633 · Cited by 338
Borba, E., & Bonfá, E. (1997) · Lupus · doi:10.1177/096120339700600610 · Cited by 289
Santos, R. D. (2001) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2001001500001 · Cited by 273
Shin, D.-J., & Osborne, T. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305417200 · Cited by 266
Diagnosis and treatment of familial hypercholesterolaemia
Hovingh, G. K., Davidson, M. H., Kastelein, J. J. P., & O'Connor, A. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht015 · Cited by 256
Secondary causes of hyperlipidemia.
Stone, N. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30179-1 · Cited by 199
Thyroid hormone signaling and the liver
Ritter, M. J., Amano, I., Hollenberg, A. N., et al. (2020) · Hepatology · doi:10.1002/hep.31296 · Cited by 188
“(38) This is attributed to an increase in receptor-mediated LDL catabolism, consistent with aforementioned animal studies.(39) TH also lowers LDL levels through reducing proprotein convertase subtilisin/kexin type 9 (PCSK9) levels, which is observed with administration of the TH analog, eprotirome, including in patien…”
Activation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.001 · Cited by 109
Flock, M. R., Green, M. H., & Kris-Etherton, P. M. (2011) · Advances in Nutrition · doi:10.3945/an.111.000422 · Cited by 82
“Early clinical evidence reported an inverse correlation between plasma cholesterol levels and TH (106).”
BackgroundMAHLEY, R. W., INNERARITY, T. L., RALL, S. C., & WEISGRABER, K. H. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb11860.x · Cited by 75
Hoffer, M. J. V., Niththyananthan, S., Naoumova, R. P., Kibirige, M. S., Frants, R. R., Havekes, L. M., & Thompson, G. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05819-4 · Cited by 32
Self-citationSecretion of testicular steroids and gonadotrophins in hypothyroidism
Kumar, A., Mohanty, B. P., & Rani, L. (2007) · Andrologia · doi:10.1111/j.1439-0272.2007.00798.x · Cited by 18
“In hypothyroidism, the receptor-mediated catabolism of LDL is reduced due to reduction in cell-surface LDL-receptor concentration (Thompson et al., 1981).”
BackgroundThe low density lipoprotein receptor: structure, function and pharmacological modulation
Catapano, A. L. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90118-6 · Cited by 9
Retnakaran, R., Connelly, P. W., & Goguen, J. (2005) · Endocrine Practice · doi:10.4158/ep.11.6.394 · Cited by 8
Metadata
- Authors
- Thompson, G. R., Soutar, A. K., Spengel, F. A., Jadhav, A., Gavigan, S. J., & Myant, N. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1981-04
- Volume
- 78
- Issue
- 4
- Pages
- 2591-2595
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012984921
- Cited by
- 274
- References
- 15
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.